SEC Filings

Filing date Form Description View
EFFECT

EFFECT

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML

Data provided by Kaleidoscope.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb